NCT03310944View on ClinicalTrials.gov

Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

December 8, 2017

Study Completion Date

December 8, 2017

Conditions

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

Interventions

DRUG

sotagliflozin (SAR439954)

"Pharmaceutical form: tablets~Route of administration: oral"

Trial Locations (1)

41460

Investigational Site Number 276001, Neuss

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY